Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 27, 2012
Architectural patterns of ovarian/pelvic high-grade serous carcinomaAmy B Bromley, Alon D Altman, Pamela Chu, et al.Plos One|March 7, 2019
Dynamics of leukocyte telomere length in pregnant women living with HIV, and HIV-negative pregnant women: A longitudinal observational studySara Saberi, Steve E Kalloger, Mayanne M T Zhu, et al.Journal of Translational Medicine|February 29, 2012
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesKaty Milne, Cheryl Alexander, John R Webb, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2015
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinomaMaziar Riazy, Steve E Kalloger, Brandon S Sheffield, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2010
Calculator for ovarian carcinoma subtype predictionSteve E Kalloger, Martin Köbel, Samuel Leung, et al.BMC Cancer|September 6, 2017
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinomaBasile Tessier-Cloutier, Steve E Kalloger, Mohammad Al-Kandari, et al.The American Journal of Surgical Pathology|March 8, 2011
FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovaryOsama M Al-Agha, Hassan F Huwait, Christine Chow, et al.American Journal of Clinical Pathology|November 21, 2009
S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survivalMelissa S DeRycke, John D Andersen, Katherine M Harrington, et al.Histopathology|September 17, 2013
Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case reviewStefan Kommoss, Cyril Blake Gilks, Friedrich Kommoss, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumorsAlon D Altman, Gregg S Nelson, Prafull Ghatage, et al.Pageof 9